Nexstim: Funding, Investors & Team (Sep 2026)
Nexstim is a medical device company focused on image-guided transcranial magnetic stimulation, dedicated to enhancing the lives of patients with unmet clinical needs. Their SmartFocus TMS technology is tailored for treating major depressive disorder. Established in 2000, Nexstim is based in Helsinki, Southern Finland.
Nexstim has raised $1.6M across 1 funding round on record, the most recent an undisclosed round of $1.6M announced in Jun 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nexstim Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Nexstim Funding Rounds
Nexstim Founders and Leadership Team
No contact details are on record for this team yet.
Nexstim Funding Compared to Other Biotechnology Startups
Nexstim's latest round of $1.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nexstim in Biotechnology and Helsinki
Companies Similar to Nexstim
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to…
Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to…
Bioretec Ltd. is a Finnish material technology company focused on the development, manufacturing and…
NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient…
They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’…
StemSight is a startup focusing on cell therapy in Tampere, Finland, where they are working on innovative…
Herantis Pharma is a company focused on addressing medical needs that have not been met by current treatments.
Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and…
Eevia Health is a Nordic life science company based in Finland and Norway, with headquarters in Seinäjoki and…
Enifer is a company that specializes in using fungal fermentation to create products from byproducts of the…
Onego Bio is a company based in the US and Finland that is transforming the food industry by utilizing…
Nexstim Funding FAQs
What does Nexstim do?
Nexstim is a medical device company focused on image-guided transcranial magnetic stimulation, dedicated to enhancing the lives of patients with unmet clinical needs. Their SmartFocus TMS technology is tailored for treating major depressive disorder. Established in 2000, Nexstim is based in Helsinki, Southern Finland.
How much funding has Nexstim raised?
Nexstim has raised $1.6M across 1 round on record. The most recent is an undisclosed round of $1.6M announced in Jun 2024.
When did Nexstim last raise funding?
Nexstim's most recent funding round on record is an undisclosed round of $1.6M, announced in Jun 2024.
Who founded Nexstim?
FundedIQ lists Pekka Puolakka (Founder) at Nexstim.
Where is Nexstim headquartered?
Nexstim is based in Helsinki, Southern Finland, Finland.
How many employees does Nexstim have?
Nexstim is in the 11-50 employee band.
How does Nexstim's funding compare to other Biotechnology startups?
Nexstim's latest round of $1.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Nexstim Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nexstim is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.